Christopher K.B. Ward
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher K.B. Ward has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- John Edward Davies
Faculty of Dentistry University of Toronto Toronto Ontario Canada
1 shared publication - Johnson Cheung
Former TMJ Surgery Fellow, Department of Oral and Maxillofacial Surgery, University of Michigan, Ann Arbor, MI
1 shared publication - Jonathan P. Troost
Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI, United States
1 shared publication - Mohamed Hakim
Private Practice Surgeon, The International Center for TMJ and Jaw Surgery, Arlington, VA
1 shared publication Rita G Gill
Institute of Biomedical Engineering (BME), University of Toronto, Toronto, Ontario, Canada
1 shared publicationRobert S Liddell
Institute of Biomedical Engineering (BME), University of Toronto, Toronto, Ontario, Canada
1 shared publication
Latest Publications
- 17 February 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 83 (5) , 510-527
Does Postoperative Disc Position Following Double Suture Arthroscopic Discopexy Correlate With Improvements in Pain and Quality of Life?
- 17 February 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 83 (5) , 510-527
Does Postoperative Disc Position Following Double Suture Arthroscopic Discopexy Correlate With Improvements in Pain and Quality of Life?
- Open Access
- 1 September 2023
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 16, 4287-4300
Umbilical Cord Stem Cell Lysate: A New Biologic Injectate for the Putative Treatment of Acute Temporomandibular Joint Inflammation
Objective: To compare in vivo, the acute anti-inflammatory effects of a lysate derived from human umbilical perivascular mesenchymal cells with the cells themselves in both an established hind-paw model of carrageenan-induced inflammation and also in the inflamed temporomandibular joint. Study Design: Human umbilical cord perivascular cells were harvested and cultured in xeno- and serum-free conditions to P3. In addition, P3 cells were used to prepare a proprietary 0.22 micron filtered lysate. First, CD1 immunocompetent mice underwent unilateral hind-paw injections of carrageenan for induction of inflammation, followed immediately by treatment with saline (negative control), 1% cell lysate, or viable cells. The contralateral paw remained un-injected with carrageenan. Paw circumference was measured prior to injections and 48 hr later and myeloperoxidase and TNF-alpha concentrations were measured post-sacrifice in excised tissue. Second, immunocompetent Male Wistar rats underwent unilateral intra-articular temporomandibular (TMJ) injections from the same treatment groups and were sacrificed at 4 and 48 hr post-injection. The contralateral TMJ remained un-injected with carrageenan. Articular tissue and synovial aspirates, from the treated TMJ were obtained for histologic and leukocyte infiltration analyses. Results: The lysate and cell-treated hind-paw demonstrated reduced tissue edema, and significantly lower concentrations of myeloperoxidase and TNF-alpha at 48 hr compared to untreated controls. Treated TMJs demonstrated lower concentrations of leukocytes in the synovium compared to controls and histologic evidence, in the peri-articular tissue, of reduced inflammation. Conclusion: In this preliminary study, both the human umbilical perivascular cells and a highly diluted lysate produced therefrom were anti-inflammatory.
- 1 September 2023
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 16, 4287-4300
Open AccessUmbilical Cord Stem Cell Lysate: A New Biologic Injectate for the Putative Treatment of Acute Temporomandibular Joint Inflammation
Objective: To compare in vivo, the acute anti-inflammatory effects of a lysate derived from human umbilical perivascular mesenchymal cells with the cells themselves in both an established hind-paw model of carrageenan-induced inflammation and also in the inflamed temporomandibular joint. Study Design: Human umbilical cord perivascular cells were harvested and cultured in xeno- and serum-free conditions to P3. In addition, P3 cells were used to prepare a proprietary 0.22 micron filtered lysate. First, CD1 immunocompetent mice underwent unilateral hind-paw injections of carrageenan for induction of inflammation, followed immediately by treatment with saline (negative control), 1% cell lysate, or viable cells. The contralateral paw remained un-injected with carrageenan. Paw circumference was measured prior to injections and 48 hr later and myeloperoxidase and TNF-alpha concentrations were measured post-sacrifice in excised tissue. Second, immunocompetent Male Wistar rats underwent unilateral intra-articular temporomandibular (TMJ) injections from the same treatment groups and were sacrificed at 4 and 48 hr post-injection. The contralateral TMJ remained un-injected with carrageenan. Articular tissue and synovial aspirates, from the treated TMJ were obtained for histologic and leukocyte infiltration analyses. Results: The lysate and cell-treated hind-paw demonstrated reduced tissue edema, and significantly lower concentrations of myeloperoxidase and TNF-alpha at 48 hr compared to untreated controls. Treated TMJs demonstrated lower concentrations of leukocytes in the synovium compared to controls and histologic evidence, in the peri-articular tissue, of reduced inflammation. Conclusion: In this preliminary study, both the human umbilical perivascular cells and a highly diluted lysate produced therefrom were anti-inflammatory.